| ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
1.037 |
Evidence |
|
| CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
1.037 |
Evidence |
|
| CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
1.037 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
1.037 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
C3 |
|
1.037 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
1.037 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
C2 |
C2: Complement C2 precursor |
1.037 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
CCT2 |
CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta |
1.037 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
1.037 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
1.037 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
CFP |
CFP, PFC: Properdin precursor |
1.037 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
1.037 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.037 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
1.037 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
1.037 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
1.037 |
Evidence |
|
| VTN |
VTN: Vitronectin precursor |
ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
1.037 |
Evidence |
|
| HPX |
HPX: Hemopexin precursor |
ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
1.037 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
HPN |
HPN, TMPRSS1: Serine protease hepsin |
1.037 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
JAK1 |
|
1.037 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
1.037 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
1.037 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.037 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
1.037 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
1.037 |
Evidence |
|